Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.010 AUD
−8.75 M AUD
17.00 K AUD
687.16 M
About AROVELLA THERAPEUTICS LIMITED
Sector
CEO
Michael Baker
Headquarters
Carlton South
Website
Founded
1999
ISIN
AU0000182784
FIGI
BBG000L6P013
Arovella Therapeutics Ltd. engages in the development invariant Natural Killer (iNKT) cell platform for treatment of cancer. Its technologies include iNKT cell therapy, CAR19-iNKT + CF33-CD19, CLDN18.2-iNKT, and DKK1-CAR-iNKT. The company was founded on December 21, 1999 and is headquartered in Carlton South, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALA is 0.190 AUD — it has increased by 5.56% in the past 24 hours. Watch AROVELLA THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AROVELLA THERAPEUTICS LIMITED stocks are traded under the ticker ALA.
ALA stock has fallen by −7.32% compared to the previous week, the last month showed zero change in price, over the last year AROVELLA THERAPEUTICS LIMITED has showed a 128.92% increase.
ALA stock is 4.40% volatile and has beta coefficient of 1.52. Track AROVELLA THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is AROVELLA THERAPEUTICS LIMITED there?
Today AROVELLA THERAPEUTICS LIMITED has the market capitalization of 201.28 M, it has decreased by −12.20% over the last week.
Yes, you can track AROVELLA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
AROVELLA THERAPEUTICS LIMITED is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ALA net income for the last half-year is −4.80 M AUD, while the previous report showed −3.95 M AUD of net income which accounts for −21.66% change. Track more AROVELLA THERAPEUTICS LIMITED financial stats to get the full picture.
No, ALA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AROVELLA THERAPEUTICS LIMITED EBITDA is −11.01 M AUD, and current EBITDA margin is −63.34 K%. See more stats in AROVELLA THERAPEUTICS LIMITED financial statements.
Like other stocks, ALA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AROVELLA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AROVELLA THERAPEUTICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AROVELLA THERAPEUTICS LIMITED stock shows the buy signal. See more of AROVELLA THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.